Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02194400 |
|
Recruitment Status :
Completed
First Posted : July 18, 2014
Last Update Posted : December 9, 2015
|
Sponsor:
Resolve Therapeutics
Information provided by (Responsible Party):
Resolve Therapeutics
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 2015 |
| Actual Study Completion Date : | November 2015 |